More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression

被引:37
作者
Lyons, Taylor [1 ]
Carhart-Harris, Robin Lester [1 ]
机构
[1] Imperial Coll London, Dept Med, Psychedel Res Grp, London, England
来源
FRONTIERS IN PSYCHOLOGY | 2018年 / 9卷
关键词
treatment-resistant depression; psilocybin; cognitive bias; pessimism; forecasting; LYSERGIC-ACID DIETHYLAMIDE; DEFAULT-MODE NETWORK; MYSTICAL-TYPE EXPERIENCES; 5-HT2A RECEPTOR-BINDING; DYSFUNCTIONAL ATTITUDES; SPIRITUAL SIGNIFICANCE; UNREALISTIC OPTIMISM; POSITIVE ILLUSIONS; THREATENING CANCER; HEALTHY-SUBJECTS;
D O I
10.3389/fpsyg.2018.01721
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background: Evidence suggests that classical psychedelics can promote enduring changes in personality, attitudes and optimism, as well as improvements in mental health outcomes. Aim: To investigate the effects of a composite intervention, involving psilocybin, on pessimism biases in patients with treatment-resistant depression (TRD). Methods: Patients with TRD (n = 15) and matched, untreated non-depressed controls (n = 15) performed the Prediction Of Future Life Events (POFLE) task. The POFLE task requires participants to predict the likelihood of certain life events occurring within a 30day period, after which the actual rate of event occurrence is reported; this gives an index of potential pessimism versus optimism bias. Psilocybin was administered in two oral dosing sessions (10 and 25 mg) one week apart. Main outcome measures were collected at baseline and one week after the second dosing session. Results: Patients showed a significant pessimism bias at baseline [t(14) = 3.260, p = 0.006; 95% CI (-0.16, -0.03), g = 1.1] which was related to the severity of their depressive symptoms (r(s) = 0.55, p = 0.017). One week after psilocybin treatment, this bias was significantly decreased [t(14) = 2.714, p = 0.017; 95% CI (-0.21, -0.02), g = 0.7] and depressive symptoms were greatly improved [t(14) = 7.900, p < 0.001; 95% CI (16.17, 28.23), g = 1.9]; moreover, the magnitude of change in both variables was significantly correlated (r = -0.57, p = 0.014). Importantly, post treatment, patients became significantly more accurate at predicting the occurrence of future life events [t(14) = 1.857, p = 0.042; 95% CI (-0.01, 0.12), g = 0.6] whereas no such change was observed in the control subjects. Conclusion: These findings suggest that psilocybin with psychological support might correct pessimism biases in TRD, enabling a more positive and accurate outlook.
引用
收藏
页数:11
相关论文
共 50 条
[41]   Treatment-Resistant Depression that Recovered after Toxoplasma Gondii Treatment: A Case Report [J].
Ozkan, Yekta ;
Sapmaz, Sermin ;
Sen, Semra ;
Ozturk, Masum ;
Kandemir, Hasan .
PSYCHIATRY AND BEHAVIORAL SCIENCES, 2020, 10 (04) :207-209
[42]   Clinical management of treatment-resistant depression [J].
Baune, Bernhard T. ;
Fromme, Sarah E. ;
Kiebs, Maximilian ;
Hurlemann, Rene .
NERVENARZT, 2024, 95 (05) :416-422
[43]   FLUOXETINE EFFICACY IN TREATMENT-RESISTANT DEPRESSION [J].
AMSTERDAM, JD ;
MAISLIN, G ;
POTTER, L .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (02) :243-261
[44]   Perspectives for therapy of treatment-resistant depression [J].
Papp, Mariusz ;
Cubala, Wieslaw Jerzy ;
Swiecicki, Lukasz ;
Newman-Tancredi, Adrian ;
Willner, Paul .
BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (17) :4181-4200
[45]   Serum cholesterol in treatment-resistant depression [J].
Papakostas, GI ;
Petersen, T ;
Sonawalla, SB ;
Merens, W ;
Iosifescu, DV ;
Alpert, JE ;
Fava, M ;
Nierenberg, AA .
NEUROPSYCHOBIOLOGY, 2003, 47 (03) :146-151
[46]   Recognition and management of treatment-resistant depression [J].
Ma, Cyrus ;
Strelow, Brittany .
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2025, 38 (01) :20-26
[47]   Intranasal esketamine for treatment-resistant depression [J].
Sobieraj, A. ;
Wang, E. ;
Kohl, P. ;
Kirsch, B. ;
Slapakova, L. ;
Schuele, C. ;
Falkai, P. .
EUROPEAN PSYCHIATRY, 2020, 63 :S117-S117
[48]   Rodent models of treatment-resistant depression [J].
Caldarone, Barbara J. ;
Zachariou, Venetia ;
King, Sarah L. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 753 :51-65
[49]   KET or ECT for treatment-resistant depression? [J].
Spies, M. ;
Kasper, S. ;
Frey, R. ;
Baldinger-Melich, P. .
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2024, 28 (3-4) :235-237
[50]   The Economic Burden of Treatment-Resistant Depression [J].
Olchanski, Natalia ;
Myers, Michelle McInnis ;
Halseth, Marilyn ;
Cyr, Philip L. ;
Bockstedt, Lindsay ;
Goss, Thomas F. ;
Howland, Robert H. .
CLINICAL THERAPEUTICS, 2013, 35 (04) :512-522